These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8390015)

  • 1. Improvement in anaemia following renal transplantation but not after erythropoietin therapy in a patient with sickle-cell disease.
    Thuraisingham RC; Roger SD; Macdougall IC; Cavill I; Stephens AD; Baker LR; Raine AE
    Nephrol Dial Transplant; 1993; 8(4):371-2. PubMed ID: 8390015
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
    Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
    Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of recombinant human erythropoietin therapy on renal transplantation.
    Ettenger RB; Marik J; Grimm P
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):57-61. PubMed ID: 1928081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
    Böcker A; Reimers E; Nonnast-Daniel B; Kühn K; Koch KM; Scigalla P; Braumann KM; Brunkhorst R; Böning D
    Contrib Nephrol; 1988; 66():165-75. PubMed ID: 3391031
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of erythropoietin to treat anaemia in end-stage renal disease.
    Ellis P; Ellis JA
    Prof Nurse; 1995 Apr; 10(7):448-50. PubMed ID: 7724635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of erythropoietin-resistant anaemia after renal transplantation in patients with homozygous sickle-cell disease.
    Breen CP; Macdougall IC
    Nephrol Dial Transplant; 1998 Nov; 13(11):2949-52. PubMed ID: 9829512
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin and chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Zingraff J; Delons S; Kreis H; Varet B
    Nouv Rev Fr Hematol (1978); 1989; 31(2):97-8. PubMed ID: 2771635
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of erythropoietin for nephrology].
    Watzinger U; Peer G; Barnas U; Mayer G; Luger A; Kovarik J; Graf H
    Wien Klin Wochenschr; 1990 Mar; 102(5):125-30. PubMed ID: 2181782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of anemia in patients with chronic renal insufficiency with recombinant human erythropoietin].
    Djukanović Lj; Lezaić V
    Srp Arh Celok Lek; 1996; 124(3-4):93-7. PubMed ID: 9102827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of recombinant erythropoietin therapy for renal transplantation.
    Ward HJ
    Am J Nephrol; 1990; 10 Suppl 2():44-7; discussion 48-52. PubMed ID: 2260618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin in anemia of renal failure in sickle cell disease.
    Roger SD; Macdougall IC; Thuraisingham RC; Raine AE
    N Engl J Med; 1991 Oct; 325(16):1175-6. PubMed ID: 1891029
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythropoietin].
    Pavlović-Kentera V
    Srp Arh Celok Lek; 1989; 117(9-10):643-8. PubMed ID: 18709763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Revolution in the treatment of chronic renal insufficiency anemia: the role of recombinant erythropoietin].
    Panas N; Turkowa M; Zgheib A; Krzesinski JM; Rorive G
    Rev Med Liege; 1990 Jun; 45(6):280-5. PubMed ID: 2367758
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of renal anaemia by recombinant human erythropoietin.
    Stifter S; Graf H
    Pol Arch Med Wewn; 1991 Jun; 85(6):329-33. PubMed ID: 1896395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Favourable effects of the treatment of renal anemia in early stage chronic renal failure].
    Kes P
    Lijec Vjesn; 2002; 124(3-4):108-9. PubMed ID: 18956830
    [No Abstract]   [Full Text] [Related]  

  • 20. Human recombinant erythropoietin: progress in clinical development.
    Kubiak W; Karwacki M; Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.